Cite
HARVARD Citation
Buchler, T. et al. (n.d.). 491PImpact of delayed addition of anti-EGFR monoclonal antibodies on the outcome of first-line therapy in metastatic colorectal cancer patients: A retrospective registry-based analysis. Annals of oncology. p. . [Online].